Hubei Jumpcan Pharmaceutical Co., Ltd Class ASSE: 600566

Announcement on the Obtaining of the Drug Registration Certificate for the Collaborative Product Masiloxavir Tablets

· Issued by Hubei Jumpcan Pharmaceutical Co., Ltd Class A via Shanghai Stock Exchange
Announcement on the Obtaining of the Drug Registration Certificate for the Collaborative Product Masiloxavir Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment